Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Michael David Garrison, Executive Vice President and President of Medical (TASE:PMCN) at Becton Dickinson & Co. (NYSE:BDX), recently sold 597 shares of the company’s common stock. The shares were sold ...

Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...

BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...

Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.

Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...

Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...

BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

Becton Dickinson (BDX) announced additional investments in its U.S. manufacturing network to add capacity for medical devices, including ...

The survey of 1,100 women was conducted in November on behalf of global medical technology company Becton, Dickinson & ...

The results of the 2024-25 academic year medical college admission test have been published, with 5,372 candidates selected ...